A PHASE 3, MULTINATIONAL, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF ARRY-371797 IN PATIENTS WITH SYMPTOMATIC DILATED CARDIOMYOPATHY DUE TO A LAMIN A/C GENE MUTATION
- Registry ID
- ARRAY-797-301 (C4411002)
- Source registry
- HEALTH_CANADA
- Status
- Ongoing
- Phase
- PHASE3
- Study type
- INTERVENTIONAL
- Sponsor
- ARRAY BIOPHARMA INC
- Start date
- 2019-06-07
- Last update
- 2018-05-25
Conditions
View on source registry